Israel Englander Pyxis Oncology, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,336,908 shares of PYXS stock, worth $4.93 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,336,908
Previous 42,400
3053.08%
Holding current value
$4.93 Million
Previous $180,000
2358.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PYXS
# of Institutions
86Shares Held
28.5MCall Options Held
134KPut Options Held
5K-
Deep Track Capital, LP Greenwich, CT4.18MShares$15.4 Million0.45% of portfolio
-
Laurion Capital Management LP New York, NY3.86MShares$14.2 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$10.3 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL2.56MShares$9.46 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$7.6 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $130M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...